Role of transporter-mediated efflux in the placental biodisposition of bupropion and its metabolite, OH-bupropion.

Cigarette smoking during pregnancy is a preventable risk factor associated with maternal and fetal complications. Bupropion is an antidepressant used successfully for smoking cessation in non-pregnant patients. Our goal is to determine whether it could benefit the pregnant patient seeking smoking cessation. The aim of this investigation was to determine the role of human placenta in the disposition of bupropion and its major hepatic metabolite, OH-bupropion. The expression of efflux transporters P-gp and BCRP was determined in placental brush border membrane (n=200) and revealed a positive correlation (p<0.05). Bupropion was transported by BCRP (K(t) 3 microM, V(max) 30 pmol/mg protein/min) and P-gp (K(t) 0.5 microM, V(max) 6 pmol/mg protein min) in placental inside-out vesicles (IOVs). OH-bupropion crossed the dually-perfused human placental lobule without undergoing further metabolism, nor was it an efflux substrate of P-gp or BCRP. In conclusion, our data indicate that human placenta actively regulates the disposition of bupropion (via metabolism, active transport), but not its major hepatic metabolite, OH-bupropion.

[1]  J. Bernaudin,et al.  Multidrug Resistance-Associated Protein MRP1 Expression in Human Gliomas: Chemosensitization to Vincristine and Etoposide by Indomethacin in Human Glioma Cell Lines Overexpressing MRP1 , 2004, Journal of Neuro-Oncology.

[2]  Shumei Yang,et al.  Direct Effects of Nicotine on Contractility of the Uterine Artery in Pregnancy , 2007, Journal of Pharmacology and Experimental Therapeutics.

[3]  K. Christensen,et al.  Smoking Habits, Nicotine Use, and Congenital Malformations , 2006, Obstetrics and gynecology.

[4]  Qiang Xu,et al.  Permeation of astilbin and taxifolin in Caco-2 cell and their effects on the P-gp. , 2009, International journal of pharmaceutics.

[5]  T. Nanovskaya,et al.  Transplacental transfer and metabolism of buprenorphine. , 2002, The Journal of pharmacology and experimental therapeutics.

[6]  G. Hankins,et al.  Bupropion metabolism by human placenta. , 2010, Biochemical pharmacology.

[7]  J. M. Rogers,et al.  Tobacco and pregnancy. , 2009, Reproductive toxicology.

[8]  E. Schisterman,et al.  Misclassification of maternal smoking status and its effects on an epidemiologic study of pregnancy outcomes. , 2007, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[9]  R. Glennon,et al.  Behavioral and biochemical investigations of bupropion metabolites. , 2003, European journal of pharmacology.

[10]  H. Kranzler,et al.  What do we know about the role of pharmacotherapy for smoking cessation before or during pregnancy? , 2009, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[11]  Y. Sawada,et al.  Kinetic Analysis of P-Glycoprotein-Mediated Transport by Using Normal Human Placental Brush-Border Membrane Vesicles , 2004, Pharmaceutical Research.

[12]  A. Puech,et al.  Antidepressant profile of bupropion and three metabolites in mice. , 1990, Pharmacopsychiatry.

[13]  T. Slotkin,et al.  Maternal tobacco smoking, nicotine replacement and neurobehavioural development , 2008, Acta paediatrica.

[14]  S. Srivastava,et al.  Adenosine triphosphate-dependent transport of doxorubicin, daunomycin, and vinblastine in human tissues by a mechanism distinct from the P-glycoprotein. , 1994, The Journal of clinical investigation.

[15]  J. Donovan,et al.  Sertraline and its metabolite desmethylsertraline, but not bupropion or its three major metabolites, have high affinity for P-glycoprotein. , 2008, Biological & pharmaceutical bulletin.

[16]  Sandy Oliver,et al.  Interventions for promoting smoking cessation during pregnancy. , 2009, The Cochrane database of systematic reviews.

[17]  Darrell R. Schroeder,et al.  A Comparison of Sustained-Release Bupropion and Placebo for Smoking Cessation , 1997 .

[18]  T. Tsuruo,et al.  Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. , 1981, Cancer research.

[19]  M. Turpeinen,et al.  Identification of bupropion urinary metabolites by liquid chromatography/mass spectrometry. , 2007, Rapid communications in mass spectrometry : RCM.

[20]  G. Koren,et al.  Transplacental transfer and biotransformation studies of nicotine in the human placental cotyledon perfused in vitro. , 1998, Life sciences.

[21]  P. Talbot.  In vitro assessment of reproductive toxicity of tobacco smoke and its constituents. , 2008, Birth defects research. Part C, Embryo today : reviews.

[22]  G. Hankins,et al.  Role of human placental apical membrane transporters in the efflux of glyburide, rosiglitazone, and metformin. , 2010, American journal of obstetrics and gynecology.

[23]  G. Hankins,et al.  Effects of nicotine-specific antibodies, Nic311 and Nic-IgG, on the transfer of nicotine across the human placenta. , 2005, Biochemical pharmacology.

[24]  T. Slotkin.  If nicotine is a developmental neurotoxicant in animal studies, dare we recommend nicotine replacement therapy in pregnant women and adolescents? , 2007, Neurotoxicology and teratology.

[25]  J. A. Johnston,et al.  Pharmacokinetics of Bupropion and its Metabolites in Cigarette Smokers versus Nonsmokers , 1997, Journal of clinical pharmacology.

[26]  G. Hankins,et al.  Opiates inhibit paclitaxel uptake by P-glycoprotein in preparations of human placental inside-out vesicles. , 2009, Biochemical pharmacology.

[27]  C. Sánchez,et al.  Comparison of the Effects of Antidepressants and Their Metabolites on Reuptake of Biogenic Amines and on Receptor Binding , 1999, Cellular and Molecular Neurobiology.

[28]  E. Waters,et al.  Interventions for promoting smoking cessation during pregnancy. , 2000, The Cochrane database of systematic reviews.

[29]  G. Hankins,et al.  Transplacental transfer and metabolism of bupropion , 2010 .